C

CH Biotech R&D
6534

Last Price

CH Biotech R&D Cash Flow Statement

Operating Activities
Metric2019202020212022202320242025
NT$592.962MNT$464.001M
NT$189.75MNT$214.119M
--
--
NT$-62.071MNT$-112.345M
NT$-182.198MNT$23.248M
NT$538.443MNT$589.023M
Investing Activities
Metric2019202020212022202320242025
NT$-588.42MNT$-127.568M
NT$-3.547MNT$-0.39M
--
--
NT$-2.8MNT$-13.563M
NT$-594.767MNT$-141.521M
Financing Activities
Metric2019202020212022202320242025
NT$-13.703MNT$-82.28M
--
NT$-369.052MNT$-421.48M
NT$-23.456MNT$-26.634M
NT$-406.211MNT$-530.394M
Cash Position
Metric2019202020212022202320242025
NT$939.93MNT$478.855M
NT$-461.075MNT$-84.727M
NT$478.855MNT$394.128M
NT$538.443MNT$589.023M
NT$-589.955MNT$-123.341M
NT$-51.512MNT$465.682M

Cash Flow Statement Waterfall

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.